Principes et modalités dapplication de lhémodialyse au traitement de linsuffisance rénale chronique, EMconsulte néphrologie, vol.18, issue.10, 2006. ,
Correlation between ACT and iCa in RDT-patients, poster EDTA, p.318, 2011. ,
Regional Citrate Anticoagulation during Hemodialysis, Blood Purification, vol.23, issue.6, pp.473-480, 2006. ,
DOI : 10.1159/000089652
Les ??tats g??n??raux du rein??: une occasion unique pour la n??phrologie fran??aise, N??phrologie & Th??rapeutique, vol.8, issue.4, pp.197-198, 2012. ,
DOI : 10.1016/j.nephro.2012.05.003
Ionic dialysance and quality control in hemodialysis, Nephrologie, vol.22, issue.5, pp.191-197, 2001. ,
Principes et modalités d'application de l'hémodialyse au traitement de l'insuffisance rénale chronique, EMconsulte Nephrologie, vol.18, issue.063, p.10, 2006. ,
H??modialyse sans ac??tate??: qu???est-ce vraiment???, N??phrologie & Th??rapeutique, vol.7, issue.2, pp.92-98, 2011. ,
DOI : 10.1016/j.nephro.2010.10.008
Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells, J Am Soc Nephrol, vol.8, issue.9, pp.1431-1436, 1997. ,
Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: Implications for dialysis hypotension, American Journal of Kidney Diseases, vol.32, issue.1, pp.115-124, 1998. ,
DOI : 10.1053/ajkd.1998.v32.pm9669432
Effects of Acetate-Free Citrate-Containing Dialysate on Metabolic Acidosis, Anemia, and Malnutrition in Hemodialysis Patients, Artificial Organs, vol.66, issue.4, pp.282-290, 2012. ,
DOI : 10.1111/j.1525-1594.2011.01349.x
Ionic dialysance: Principle and review of its clinical relevance for quantification of hemodialysis efficiency, Hemodialysis International, vol.127, issue.1, pp.111-119, 2005. ,
DOI : 10.1046/j.1525-1594.2002.06817.x
Recent developments in conductivity monitoring of haemodialysis session, Nephrology Dialysis Transplantation, vol.14, issue.11, pp.2607-2613, 1999. ,
DOI : 10.1093/ndt/14.11.2607
Do dialysate conductivity measurements provide conductivity clearance or ionic dialysance?, Kidney International, vol.70, issue.10, pp.1682-1686, 2006. ,
DOI : 10.1038/sj.ki.5001840
Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis, American Journal of Kidney Diseases, vol.38, issue.3, pp.565-574, 2001. ,
DOI : 10.1053/ajkd.2001.26874
What are the anticoagulation options for intermittent hemodialysis? Nature reviews, Nephrology, vol.7, issue.9, pp.499-508, 2011. ,
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.6. Chronic graft dysfunction. Late recurrence of other diseases, Nephrol Dial Transplant, vol.17, issue.4, pp.18-19, 2002. ,
Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h after bolus administration as an anticoagulant in haemodialysis, Nephrology Dialysis Transplantation, vol.18, issue.11, pp.2348-2353, 2003. ,
DOI : 10.1093/ndt/gfg396
When Heparins Promote Thrombosis: Review of Heparin-Induced Thrombocytopenia, Circulation, vol.111, issue.20, pp.2671-2683, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.104.518563
Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients, American Journal of Kidney Diseases, vol.40, issue.5, pp.990-995, 2002. ,
DOI : 10.1053/ajkd.2002.36331
Recommended and actual lepirudin doses in patients with renal insufficiency, Am J Health-syst Pharm, vol.60, issue.24, pp.2588-2593, 2003. ,
Use of a Low-Molecular-Weight Heparinoid (Danaparoid Sodium) for Continuous Renal Replacement Therapy in Intensive Care Patients, Clinical and Applied Thrombosis/Hemostasis, vol.115, issue.4, pp.300-304, 2001. ,
DOI : 10.1177/107602960100700409
Use of fondaparinux (ARIXTRA(R)) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II, Nephrology Dialysis Transplantation, vol.20, issue.2, pp.444-446, 2005. ,
DOI : 10.1093/ndt/gfh544
Prostacyclin versus Citrate in Continuous Haemodiafiltration: An Observational Study in Patients with High Risk of Bleeding, Blood Purification, vol.23, issue.4, pp.325-329, 2005. ,
DOI : 10.1159/000087770
Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration, Critical Care Medicine, vol.26, issue.7, pp.1208-1212, 1998. ,
DOI : 10.1097/00003246-199807000-00021
H??MODIALYSIS WITHOUT HEPARIN IS POSSIBLE, The Lancet, vol.314, issue.8142, pp.579-580, 1979. ,
DOI : 10.1016/S0140-6736(79)91631-3
Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin, Nephrology Dialysis Transplantation, vol.21, issue.2, pp.444-449, 2006. ,
DOI : 10.1093/ndt/gfi203
Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation, Nephrology Dialysis Transplantation, vol.19, issue.1, pp.164-170, 2004. ,
DOI : 10.1093/ndt/gfg459
Preventing hemorrhage in high-risk hemodialysis: Regional versus low-dose heparin, Kidney International, vol.16, issue.4, pp.513-518, 1979. ,
DOI : 10.1038/ki.1979.157
Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding, J Nephrol, vol.16, issue.4, pp.566-571, 2003. ,
Filter Run Time in CVVH: Pre- versus Post-Dilution and Nadroparin versus Regional Heparin-Protamine Anticoagulation, Blood Purification, vol.23, issue.3, pp.175-180, 2005. ,
DOI : 10.1159/000083938
Correlation between ACT and iCa in RDT-patients. poster, EDTA, vol.318, 2011. ,
Reducing the Hemorrhagic Complications of Hemodialysis: A Controlled Comparison of Low-Dose Heparin and Citrate Anticoagulation, American Journal of Kidney Diseases, vol.9, issue.2, pp.147-153, 1987. ,
DOI : 10.1016/S0272-6386(87)80092-6
Effect of anticoagulation on blood membrane interactions during hemodialysis, Kidney International, vol.56, issue.4, pp.1578-1583, 1999. ,
DOI : 10.1046/j.1523-1755.1999.00671.x
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients, Kidney International, vol.67, issue.6, pp.2361-2367, 2005. ,
DOI : 10.1111/j.1523-1755.2005.00342.x
Heparin-Coated Polyacrylonitrile Membrane Versus Regional Citrate Anticoagulation: A Prospective Randomized Study of 2 Anticoagulation Strategies in Patients at Risk of Bleeding, American Journal of Kidney Diseases, vol.49, issue.5, pp.642-649, 2007. ,
DOI : 10.1053/j.ajkd.2007.02.001
Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study, Intensive Care Medicine, vol.30, issue.2, pp.260-265, 2004. ,
DOI : 10.1007/s00134-003-2047-x
Citrate anticoagulation for continuous venovenous hemofiltration*, Critical Care Medicine, vol.37, issue.2, pp.545-552, 2009. ,
DOI : 10.1097/CCM.0b013e3181953c5e
Citrate for long-term hemodialysis: Prospective study of 1,009 consecutive high-flux treatments in 59 patients, American Journal of Kidney Diseases, vol.45, issue.3, pp.557-564, 2005. ,
DOI : 10.1053/j.ajkd.2004.12.002
Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients, Kidney International, vol.49, issue.3, pp.806-813, 1996. ,
DOI : 10.1038/ki.1996.112
Citrate versus heparin anticoagulation in chronic haemodialysis patients, Nephrol Dial Transplant, vol.8, issue.11, pp.1228-1233, 1993. ,
REGIONAL ANTICOAGULATION DURING HEMODIALYSIS USING CITRATE, The American Journal of the Medical Sciences, vol.242, issue.2, pp.32-43, 1961. ,
DOI : 10.1097/00000441-196107000-00005
Regional Citrate Anticoagulation for Hemodialysis in the Patient at High Risk for Bleeding, New England Journal of Medicine, vol.308, issue.5, pp.258-261, 1983. ,
DOI : 10.1056/NEJM198302033080506
Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients, Kidney International, vol.38, issue.5, pp.976-981, 1990. ,
DOI : 10.1038/ki.1990.300
Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate, American Journal of Kidney Diseases, vol.39, issue.2, pp.315-323, 2002. ,
DOI : 10.1053/ajkd.2002.30551
Increased Efficiency of Hemodialysis with Citrate Dialysate: A Prospective Controlled Study, Clinical Journal of the American Society of Nephrology, vol.4, issue.9, pp.1459-1464, 2009. ,
DOI : 10.2215/CJN.02590409
Dialysate made from dry chemicals using citric acid increases dialysis dose, American Journal of Kidney Diseases, vol.35, issue.3, pp.493-499, 2000. ,
DOI : 10.1016/S0272-6386(00)70203-4
Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes, BMC Nephrology, vol.40, issue.1, p.7, 2009. ,
DOI : 10.1172/JCI107749
Anticoagulation during haemodialysis using a citrate-enriched dialysate: a feasibility study, Nephrology Dialysis Transplantation, vol.26, issue.2, pp.641-646, 2011. ,
DOI : 10.1093/ndt/gfq396
Regional Citrate Anticoagulation during Hemodialysis, Blood Purification, vol.23, issue.6, pp.473-480, 2005. ,
DOI : 10.1159/000089652
Clinical practice guidelines for hemodialysis adequacy, update 2006, Am J Kidney Dis, vol.48, issue.1, pp.2-90, 2006. ,
Evaluation of Three Different Methods to Prevent Dialyzer Clotting Without Causing Systemic Anticoagulation Effect, Artificial Organs, vol.24, issue.7, pp.83-88, 2011. ,
DOI : 10.1111/j.1525-1594.2010.01038.x
Risk Factors of System Clotting in Heparin-Free Haemodialysis, Nephrology Dialysis Transplantation, vol.5, issue.9, pp.802-807, 1990. ,
DOI : 10.1093/ndt/5.9.802
Heparin free dialysis: Comparative data and results in high risk patients, Kidney International, vol.31, issue.6, pp.1351-1355, 1987. ,
DOI : 10.1038/ki.1987.149
Controlled Study of Heparin versus Epoprostenol Sodium (Prostacyclin) as the Sole Anticoagulant for Chronic Hemodialysis, Blood Purification, vol.9, issue.5-6, pp.5-6296, 1991. ,
DOI : 10.1159/000170027
Low-dose and heparin-free hemodialysis in children, Pediatric Nephrology, vol.83, issue.2, pp.220-224, 1991. ,
DOI : 10.1007/BF01095957
Hemodialysis Without Anticoagulation, American Journal of Kidney Diseases, vol.5, issue.1, pp.32-35, 1985. ,
DOI : 10.1016/S0272-6386(85)80132-3
Effects of Citrate Acid Concentrate (Citrasate??) on Heparin N Requirements and Hemodialysis Adequacy: A Multicenter, Prospective Noninferiority Trial, Blood Purification, vol.33, issue.1-3, pp.1-3199, 2012. ,
DOI : 10.1159/000334157
A significant proportion of patients treated with citrate containing dialysate need additional anticoagulation, The International Journal of Artificial Organs, vol.36, issue.1, pp.1-6, 2013. ,
DOI : 10.5301/ijao.5000172
Safe Use of Citric Acid-Based Dialysate and Heparin Removal in Postdilution Online Hemodiafiltration, Blood Purification, vol.34, issue.3-4, pp.3-4336, 2012. ,
DOI : 10.1159/000345342
Duocart Biofiltration, ASAIO Journal, vol.45, issue.3, pp.151-156, 1999. ,
DOI : 10.1097/00002480-199905000-00009
Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation, American Journal of Kidney Diseases, vol.33, issue.4, p.8, 1999. ,
DOI : 10.1016/S0272-6386(99)70249-0
Cardiac arrest after hypertonic citrate anticoagulation for chronic hemodialysis, ASAIO Trans, vol.36, issue.3, pp.217-219, 1990. ,
Severe Metabolic Alkalosis Complicating Regional Citrate Hemodialysis, American Journal of Kidney Diseases, vol.9, issue.3, pp.235-236, 1987. ,
DOI : 10.1016/S0272-6386(87)80061-6
Metabolic alkalosis induced by regional citrate hemodialysis, ASAIO Trans, vol.35, issue.1, pp.22-25, 1989. ,
Standard Citrate Versus Sequential Citrate/Anticoagulant-free Anticoagulation During Hemodialysis: A Randomized Trial, Artificial Organs, vol.36, issue.0, pp.77-81, 2008. ,
DOI : 10.1097/01.CCM.0000084871.76568.E6
Safety and Efficacy of Regional Citrate Anticoagulation During 8-Hour Sustained Low-Efficiency Dialysis, Clinical Journal of the American Society of Nephrology, vol.3, issue.3, pp.736-742, 2008. ,
DOI : 10.2215/CJN.03460807
Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding, Nephrology Dialysis Transplantation, vol.25, issue.10, pp.3337-3342, 2010. ,
DOI : 10.1093/ndt/gfq225
High-Efficiency Postdilution Online Hemodiafiltration Reduces All-Cause Mortality in Hemodialysis Patients, Journal of the American Society of Nephrology, vol.24, issue.3, pp.487-497, 2013. ,
DOI : 10.1681/ASN.2012080875
Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation, Blood, vol.97, issue.9, pp.2914-2915, 2001. ,
DOI : 10.1182/blood.V97.9.2914
Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis, Nephrology Dialysis Transplantation, vol.21, issue.1, pp.153-159, 2006. ,
DOI : 10.1093/ndt/gfi069
Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation, J Am Soc Nephrol, vol.7, issue.2, pp.234-241, 1996. ,
Activation of the kallikrein-kinin system in hemodialysis: Role of membrane electronegativity, blood dilution, and pH, Kidney International, vol.55, issue.3, pp.1097-1103, 1999. ,
DOI : 10.1046/j.1523-1755.1999.0550031097.x